Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Weisman

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Lupus|May 11, 2013
Pain and depression predict self-reported fatigue/energy in lupusI Moldovan, D Cooray, F Carr, et al.
Lancet (London, England)|January 6, 2000
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study GroupR Maini, E W St Clair, F Breedveld, et al.
The Journal of Rheumatology|November 11, 1999
Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study GroupE W Ehrich, T J Schnitzer, H McIlwain, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab in active early rheumatoid arthritisF C Breedveld, P Emery, E Keystone, et al.
Arthritis Research|July 5, 2001
Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritisL Moreland, R Gugliotti, K King, et al.
Arthritis and Rheumatism|March 4, 1998
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trialM L Barnett, J M Kremer, E W St Clair, et al.
Lupus|April 5, 2013
Spanish LupusPRO: cross-cultural validation study for lupusM Jolly, S Toloza, J Block, et al.
Nature Ecology & Evolution|February 27, 2019
Pervasive population genomic consequences of genome duplication in Arabidopsis arenosaPatrick Monnahan, Filip Kolář, Pierre Baduel, et al.
The EMBO Journal|October 1, 2003
A conserved catalytic residue in the ubiquitin-conjugating enzyme familyPei-Ying Wu, Mary Hanlon, Michael Eddins, et al.
The New England Journal of Medicine|November 30, 2000
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study GroupP E Lipsky, D M van der Heijde, E W St Clair, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Lupus|May 11, 2013
Pain and depression predict self-reported fatigue/energy in lupusI Moldovan, D Cooray, F Carr, et al.
Lancet (London, England)|January 6, 2000
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study GroupR Maini, E W St Clair, F Breedveld, et al.
The Journal of Rheumatology|November 11, 1999
Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study GroupE W Ehrich, T J Schnitzer, H McIlwain, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab in active early rheumatoid arthritisF C Breedveld, P Emery, E Keystone, et al.
Arthritis Research|July 5, 2001
Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritisL Moreland, R Gugliotti, K King, et al.
Arthritis and Rheumatism|March 4, 1998
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trialM L Barnett, J M Kremer, E W St Clair, et al.
Lupus|April 5, 2013
Spanish LupusPRO: cross-cultural validation study for lupusM Jolly, S Toloza, J Block, et al.
Nature Ecology & Evolution|February 27, 2019
Pervasive population genomic consequences of genome duplication in Arabidopsis arenosaPatrick Monnahan, Filip Kolář, Pierre Baduel, et al.
The EMBO Journal|October 1, 2003
A conserved catalytic residue in the ubiquitin-conjugating enzyme familyPei-Ying Wu, Mary Hanlon, Michael Eddins, et al.
The New England Journal of Medicine|November 30, 2000
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study GroupP E Lipsky, D M van der Heijde, E W St Clair, et al.
Pageof 14